Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
71 participants
INTERVENTIONAL
2016-10-31
2017-09-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Short-term Supplementation of OliPhenolia® on Fat Oxidation.
NCT07210099
Radicle Energy 24: A Study of Health and Wellness Products on Fatigue and Related Health Outcomes
NCT06201689
Investigating a Natural Antioxidant Food Product on Oxidative Stress in Recreationally Active Participants
NCT04959006
The Effects of Antioxidant Supplementation on Multiple Endurance Race Performance, Physiology, and Recovery.
NCT04314596
Influence of the Time of Day in the Effect of Caffeine on Maximal Fat Oxidation During Exercise in Women
NCT05880186
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Calanus oil
4 capsules of 500 mg Calanus oil once every day
Calanus oil
Placebo
4 capsules of 500 mg dietary oil once every day
placebo dietary oil
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Calanus oil
placebo dietary oil
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index (BMI) between 18,5 and 29,9
Exclusion Criteria
* diagnosed coronary artery disease
* Any other significant medical condition
* medication effecting exercise capacity (e.i. betablockers)
* Pregnancy
* Participation in other clinical trials
* Shellfish allergies
* Systolic blood pressure \> 170 mmHG, or diastolic BP \> 105 mmHG.
* contraindications for maximal exercise testing
30 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Tromso
OTHER
Calanus
INDUSTRY
Norwegian University of Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ulrik Wisløff, phd prof
Role: STUDY_DIRECTOR
Norwegian University of Science and Technology
Trine Karlsen, phd
Role: PRINCIPAL_INVESTIGATOR
Norwegian University of Science and Technology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institutt for Medisinsk Biologi, UiT Norges arktiske universitet
Tromsø, , Norway
KG Jebsen-senter for Hjertetrening, NTNU
Trondheim, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015/2303
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.